PeopleBeatingCancer supports an evidence-based integrative approach to cancer care. For most newly diagnosed patients, FDA-approved therapies form the foundation of treatment, while evidence-based complementary therapies may help reduce side effects and improve survivorship.
Click the orange button to the right to learn more.
Melanoma Surgery: What Patients Need to Know. For many people diagnosed with melanoma, surgery is the first—and sometimes the only—treatment they will need. And because melanoma is notoriously difficult to diagnose, consider getting a second opinion.
But “melanoma surgery” can mean several different things. A patient might have an initial biopsy, a second operation called a wide local excision, a sentinel lymph node biopsy, reconstructive surgery, or—in more advanced situations—surgery involving lymph nodes or metastatic tumors.
The amount of surgery generally depends less on how large the melanoma looks on the surface than on what the pathology report shows underneath the microscope.
Remember that with a melanoma diagnosis, stage dictates prognosis and often your therapy plan.
For patients, one of the most important numbers is Breslow thickness: how deeply the melanoma has grown into the skin.
This post explains what melanoma patients should understand before surgery, during treatment, and after surgery, including questions to ask their surgeon and evidence-based strategies that may support recovery.
PeopleBeatingCancer.org perspective: Surgery is one of the most evidence-supported treatments available for localized melanoma. Complementary therapies may have a role in recovery, general health, and survivorship, but they should not be considered substitutes for adequate surgical removal of melanoma.
I am a long-term survivor of an incurable blood cancer called multiple myeloma. My research and experience with evidence-based non-conventional therapies are the reason why I have lived in complete remission from my incurable blood cancer since achieving complete remission in early 1999. I have learned that the best way to manage aggressive cancers is to combine the best of conventional and evidence-based non-conventional therapies.
I have come to believe that therapy-induced side effects can be life-threatening while ruining quality of life. Consider therapies shown to reduce possible side effects.
Scroll down the page and post a question or a comment if there’s anything you’d like to know about surgery for melanoma.
Good luck,
Melanoma begins in melanocytes, the pigment-producing cells of the skin.
When melanoma is found while it is still localized, the primary goal is straightforward:
Remove the melanoma completely before cancer cells have an opportunity to spread.
The National Cancer Institute lists surgical excision as the standard treatment for stage 0 melanoma and as a central component of treatment for stages I and II.
That makes early detection especially important. A thin melanoma that can be completely removed surgically represents a very different clinical situation from melanoma that has reached lymph nodes or distant organs.
For many patients, treatment occurs in several steps.
A suspicious mole or lesion is removed—or sampled—and examined by a pathologist.
The pathology report may include:
Once melanoma has been confirmed, the information in this report helps determine how much additional surgery is necessary.
Most patients with melanoma undergo a wide local excision (WLE).
Even if the dermatologist appears to have removed the entire melanoma during the original biopsy, additional tissue around the biopsy site is usually removed.
The goal is to create a margin of normal-looking skin around the original melanoma and obtain microscopically negative margins.
| Melanoma thickness | Typical clinical surgical margin |
|---|---|
| Melanoma in situ | At least 5 mm; sometimes wider margins are needed |
| Invasive melanoma <1 mm | 1 cm |
| Melanoma 1–2 mm | 1–2 cm |
| Melanoma >2 mm | 2 cm |
These margins are measured outward from the melanoma or previous biopsy scar, not from the microscopic edge seen by the pathologist. Current standards generally use 1 cm for melanomas under 1 mm thick, 1–2 cm for melanomas between 1 and 2 mm, and 2 cm for melanomas greater than 2 mm.
Importantly, more surgery isn’t necessarily better. Studies of wider margins have not demonstrated that very large excisions improve survival compared with appropriately selected narrower margins. For melanomas thicker than 2 mm, for example, 2-cm margins are generally recommended because wider margins have not demonstrated additional benefit.
For some patients, melanoma surgery includes a sentinel lymph node biopsy (SLNB).
The sentinel lymph node is the first lymph node—or group of nodes—to which melanoma cells would most likely travel.
Before or during surgery, a tracer is injected near the melanoma site. The surgeon identifies the draining lymph node or nodes and removes them for examination by a pathologist.
The purpose of SLNB is primarily staging.
It answers an important question:
Has melanoma begun spreading beyond the skin even though the lymph nodes appear normal?
Tumor thickness plays an important role.
The NCI notes that SLNB may be considered for melanomas measuring at least 0.8 mm thick and for certain thinner melanomas with higher-risk characteristics such as ulceration.
A simplified way to think about the decision is:
| Melanoma | SLNB consideration |
| <0.8 mm without ulceration | Usually not recommended |
| <0.8 mm with ulceration | May be considered |
| 0.8–1.0 mm | Discuss risks and benefits |
| >1.0 mm | Commonly recommended/strongly considered depending on clinical circumstances |
This is a decision worth discussing carefully with your melanoma surgeon because SLNB can change the stage of the disease and potentially influence recommendations for additional treatment.
A positive sentinel lymph node means melanoma cells have been detected in a regional lymph node.
That can change both the stage and treatment strategy.
Years ago, a positive sentinel node frequently led automatically to removal of many additional lymph nodes—a procedure called completion lymph node dissection.
That approach has changed.
Clinical trials showed that routine completion lymph node dissection does not necessarily improve melanoma-specific survival compared with careful observation in appropriately selected patients. Ultrasound surveillance of the lymph-node basin has therefore become an accepted strategy for many patients with microscopic sentinel-node involvement.
A positive sentinel node may also lead to discussions about:
This is where management increasingly becomes multidisciplinary rather than simply surgical.
| Stage | Typical surgical approach |
| Stage 0 — melanoma in situ | Wide local excision |
| Stage I | Wide local excision; SLNB may be considered depending on thickness/risk |
| Stage II | Wide local excision + consideration of SLNB |
| Stage III | Surgery when appropriate plus evaluation of lymph nodes and systemic therapy |
| Stage IV | Surgery used selectively; systemic therapy usually becomes central |
Surgery can sometimes be useful even when melanoma has spread, particularly when there are only one or a few metastatic sites that can be removed. But metastatic melanoma is generally unlikely to be cured by surgery alone.
Sometimes.
The answer depends on:
Small excisions can often be closed directly with stitches.
Larger excisions may require a:
Skin graft — skin is taken from another part of the body and placed over the surgical defect.
Local flap — nearby skin and tissue are repositioned to cover the wound.
Plastic or reconstructive surgeon — particularly useful for melanoma involving cosmetically or functionally sensitive areas such as the face, nose, ears, hands, or feet.
This is an excellent topic to discuss before surgery rather than after it.
Most melanoma surgery is well tolerated, but surgery still carries risks.
| Possible side effect | What patients should know |
| Pain | Usually temporary and manageable |
| Bleeding | Usually minor but occasionally requires treatment |
| Infection | Watch for redness, warmth, drainage, fever, or worsening pain |
| Scarring | Depends on excision size and location |
| Numbness | Small sensory nerves may be affected |
| Limited movement | More important when surgery occurs near joints |
| Wound separation | Occasionally wounds heal slowly or reopen |
| Seroma | Fluid can collect after lymph-node procedures |
| Lymphedema | More significant after extensive lymph-node surgery |
| Cosmetic changes | Particularly important with facial/head-and-neck melanoma |
Lymphedema deserves special attention when larger numbers of lymph nodes are removed. Removing lymph nodes from the groin or underarm can interfere with normal lymphatic drainage and cause chronic swelling of an arm or leg.
The risk is much lower with sentinel lymph node biopsy than with complete lymph-node dissection.
I believe cancer patients benefit from understanding exactly what the surgery is intended to accomplish.
Consider asking:
Surgery is not necessarily the end of melanoma care.
The final pathology report may determine whether additional treatment is appropriate.
Your oncology team may evaluate:
Patients with higher-risk stage II or stage III melanoma may be offered adjuvant systemic therapy, including immunotherapy in appropriate situations.
One of the most important lessons for melanoma survivors is:
Removing the melanoma doesn’t eliminate the need for surveillance.
People who have had melanoma have an increased risk of developing another melanoma. Follow-up therefore involves watching both for recurrence and for entirely new skin cancers.
A typical follow-up strategy may include:
For people with early-stage melanoma that has been completely removed, physical examinations might initially occur every 6–12 months. People with thicker or more advanced melanomas may initially be examined every 3–6 months, although surveillance should always be individualized.
This is where it is especially important to distinguish between two questions:
Can something help me recover from surgery or improve my overall health?
versus
Has it been proven to prevent melanoma recurrence?
Those are not the same question.
Nutrition, exercise, sleep, stress management, correcting nutrient deficiencies, and other lifestyle strategies may support general health and recovery.
But none should be presented as a replacement for adequate melanoma surgery or evidence-based oncology care.
| Strategy | Evidence rating | What the evidence suggests |
| Sun/UV protection | 🟢 Strong | Essential component of melanoma survivorship and prevention of additional UV-related skin damage |
| Regular skin self-examination | 🟢 Strong | Important survivorship strategy for detecting suspicious new or recurrent lesions |
| Regular physical activity | 🟡 Moderate | Strong general survivorship benefits; melanoma-specific recurrence evidence is less certain |
| Healthy Mediterranean-style diet | 🟡 Moderate | Supports cardiovascular and metabolic health; direct melanoma-recurrence evidence remains limited |
| Correcting vitamin D deficiency | 🟡 Moderate / evolving | Vitamin D status and melanoma outcomes remain an active area of research; supplementation should ideally be based on measured levels |
| Omega-3 fatty acids | 🟠 Preliminary for melanoma | Biologically plausible anti-inflammatory effects, but insufficient evidence to claim prevention of melanoma recurrence |
| Curcumin | 🟠 Preliminary | Laboratory and preclinical melanoma research is interesting, but clinical evidence remains inadequate |
| Medicinal mushrooms / immune supplements | 🔴 Insufficient melanoma-specific evidence | Claims often exceed available clinical evidence |
| Replacing surgery with supplements or alternative therapies | 🔴 Not supported | No complementary therapy has evidence comparable with surgical excision for localized melanoma |
🟢 Strong evidence — supported by clinical evidence and/or established guideline-based practice.
🟡 Moderate evidence — meaningful human evidence exists, but important uncertainties remain.
🟠 Preliminary evidence — promising biological, observational, or early clinical evidence, but not enough to establish clinical benefit.
🔴 Insufficient/not supported — evidence is inadequate to recommend the intervention for melanoma control.
The purpose of this system is not to label therapies simply as “good” or “bad.” It is to help cancer patients understand how much evidence actually supports a particular claim.
Learn more about supplements and skin cancer
Patients should tell their surgeon about every supplement they take.
Certain supplements can potentially influence:
Your surgeon or anesthesiologist may recommend temporarily stopping particular supplements before surgery.
Do not assume that something is automatically safe around surgery simply because it is “natural.”
Contact your medical team if you develop:
Follow the postoperative instructions provided by your surgical team, since wound care varies considerably depending on the procedure.
For localized melanoma, surgery can be remarkably effective.
But patients should understand that melanoma surgery isn’t simply about “cutting out a mole.”
The pathology report determines how aggressively the melanoma needs to be treated.
The three questions I would want every newly diagnosed melanoma patient to understand are:
1. How thick is my melanoma?
2. How wide a surgical margin do I need?
3. Should I have a sentinel lymph node biopsy?
Those answers help determine the extent of surgery, melanoma stage, prognosis, and whether additional treatment should be considered.
And once surgery is over, the next phase begins:
melanoma survivorship.
That means protecting your skin, monitoring it, maintaining regular dermatology follow-up, understanding your recurrence risk, and doing what you reasonably can to support your long-term health.
National Cancer Institute — Melanoma Treatment (Health Professional Version)
Comprehensive evidence review covering melanoma staging, surgical margins, sentinel lymph-node biopsy, and treatment by stage. NCI Melanoma Treatment PDQ
National Cancer Institute — Melanoma Treatment (Patient Version)
Patient-friendly overview of melanoma diagnosis, staging, and treatment. NCI Melanoma Treatment for Patients
National Cancer Institute — Sentinel Lymph Node Biopsy
Explains how sentinel-node biopsy works and its role in melanoma staging. NCI Sentinel Lymph Node Biopsy Fact Sheet
American Cancer Society — Surgery for Melanoma Skin Cancer
Overview of wide excision, lymph-node surgery, surgery for metastatic melanoma, and potential complications. American Cancer Society: Surgery for Melanoma
American Cancer Society — Living as a Melanoma Survivor
Useful resource covering follow-up schedules, skin self-examination, recurrence, and long-term survivorship. American Cancer Society: Melanoma Survivorship
Is surgery enough to cure melanoma?
For many early-stage melanomas, surgery may be the only treatment necessary. Higher-risk or more advanced melanoma may require immunotherapy, targeted therapy, or other treatment.
How much skin is removed during melanoma surgery?
The surgical margin generally depends on Breslow thickness. Typical margins range from at least 5 mm for melanoma in situ to 2 cm for melanomas thicker than 2 mm.
When is sentinel lymph node biopsy recommended for melanoma?
It is commonly discussed for invasive melanomas around 0.8 mm or thicker and for selected thinner melanomas with high-risk characteristics.
What happens if melanoma is found in the sentinel lymph node?
A positive sentinel node changes melanoma staging and may lead to imaging, lymph-node surveillance, and consideration of adjuvant systemic therapy.
Can melanoma come back after surgery?
Yes. Recurrence risk depends heavily on the original melanoma’s stage and pathological features. Melanoma survivors also have an increased risk of developing another melanoma, making long-term skin surveillance important.
How long should melanoma patients be monitored after surgery?
Follow-up frequency depends on stage and recurrence risk. Because melanoma can recur and survivors remain at increased risk of another melanoma, ongoing dermatologic surveillance is important.